These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 21762310)

  • 1. Autologous transplantation of blood-derived stem/progenitor cells for ischaemic heart disease.
    Wen Y; Meng L; Ding Y; Ouyang J
    Int J Clin Pract; 2011 Aug; 65(8):858-65. PubMed ID: 21762310
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Efficacy of autologous bone marrow-derived cells transfer for patients with chronic ischemic heart disease: a meta-analysis].
    Zhang CY; Sun AJ; Ge JB; Zhang SN; Wang KQ; Zou YZ
    Zhonghua Xin Xue Guan Bing Za Zhi; 2010 Jul; 38(7):656-61. PubMed ID: 21055294
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of intracoronary cell therapy on left ventricular function in the setting of acute myocardial infarction: a meta-analysis of randomised controlled clinical trials.
    Delewi R; Andriessen A; Tijssen JG; Zijlstra F; Piek JJ; Hirsch A
    Heart; 2013 Feb; 99(4):225-32. PubMed ID: 22875736
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomized controlled trials on the therapeutic effects of adult progenitor cells for myocardial infarction: meta-analysis.
    Jiang M; He B; Zhang Q; Ge H; Zang MH; Han ZH; Liu JP; Li JH; Zhang Q; Li HB; Jin Y; He Q; Gong XR; Yin XY
    Expert Opin Biol Ther; 2010 May; 10(5):667-80. PubMed ID: 20384520
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bone marrow-derived mononuclear cell therapy for patients with ischemic heart disease and ischemic heart failure.
    Wen Y; Chen B; Wang C; Ma X; Gao Q
    Expert Opin Biol Ther; 2012 Dec; 12(12):1563-73. PubMed ID: 22953786
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential effect of intracoronary infusion of mobilized peripheral blood stem cells by granulocyte colony-stimulating factor on left ventricular function and remodeling in patients with acute myocardial infarction versus old myocardial infarction: the MAGIC Cell-3-DES randomized, controlled trial.
    Kang HJ; Lee HY; Na SH; Chang SA; Park KW; Kim HK; Kim SY; Chang HJ; Lee W; Kang WJ; Koo BK; Kim YJ; Lee DS; Sohn DW; Han KS; Oh BH; Park YB; Kim HS
    Circulation; 2006 Jul; 114(1 Suppl):I145-51. PubMed ID: 16820564
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effectiveness and tolerability of administration of granulocyte colony-stimulating factor on left ventricular function in patients with myocardial infarction: a meta-analysis of randomized controlled trials.
    Kang S; Yang Y; Li CJ; Gao R
    Clin Ther; 2007 Nov; 29(11):2406-18. PubMed ID: 18158081
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The clinical study of autologous peripheral blood stem cell transplantation by intracoronary infusion in patients with acute myocardial infarction (AMI).
    Li ZQ; Zhang M; Jing YZ; Zhang WW; Liu Y; Cui LJ; Yuan L; Liu XZ; Yu X; Hu TS
    Int J Cardiol; 2007 Jan; 115(1):52-6. PubMed ID: 16822566
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stem cell mobilization by granulocyte colony-stimulating factor for myocardial recovery after acute myocardial infarction: a meta-analysis.
    Zohlnhöfer D; Dibra A; Koppara T; de Waha A; Ripa RS; Kastrup J; Valgimigli M; Schömig A; Kastrati A
    J Am Coll Cardiol; 2008 Apr; 51(15):1429-37. PubMed ID: 18402895
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety and feasibility of combined granulocyte colony stimulating factor and erythropoetin based-stem cell therapy using intracoronary infusion of peripheral blood stem cells in patients with recent anterior myocardial infarction: one-year follow-up of a phase 1 study.
    Santoso T; Irawan C; Alwi I; Aziz A; Kosasih A; Inggriani S; Saputra A; Wintery M; Lison L
    Acta Med Indones; 2011 Apr; 43(2):112-21. PubMed ID: 21785174
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intracoronary autologous bone marrow stem cells transfer for patients with acute myocardial infarction: a meta-analysis of randomised controlled trials.
    Zhang SN; Sun AJ; Ge JB; Yao K; Huang ZY; Wang KQ; Zou YZ
    Int J Cardiol; 2009 Aug; 136(2):178-85. PubMed ID: 18644638
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Restoration of left ventricular synchronous contraction after acute myocardial infarction by stem cell therapy: new insights into the therapeutic implication of stem cell therapy for acute myocardial infarction.
    Chang SA; Kim HK; Lee HY; Choi SY; Koo BK; Kim YJ; Sohn DW; Oh BH; Park YB; Choi YS; Kang HJ; Kim HS
    Heart; 2008 Aug; 94(8):995-1001. PubMed ID: 17974698
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transplanted human cord blood-derived unrestricted somatic stem cells improve left-ventricular function and prevent left-ventricular dilation and scar formation after acute myocardial infarction.
    Ghodsizad A; Niehaus M; Kögler G; Martin U; Wernet P; Bara C; Khaladj N; Loos A; Makoui M; Thiele J; Mengel M; Karck M; Klein HM; Haverich A; Ruhparwar A
    Heart; 2009 Jan; 95(1):27-35. PubMed ID: 18519547
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Safety and efficacy of intracoronary transplantation of G-CSF mobilized autologous peripheral blood stem cells in patients with acute myocardial infarction].
    Li ZQ; Zhang M; Jin YZ; Zhang WW; Liu Y; Yuan L; Cui LJ; Liu XZ; Yu X; Hu TS
    Zhonghua Xin Xue Guan Bing Za Zhi; 2006 Feb; 34(2):99-102. PubMed ID: 16626571
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stem cell treatment for acute myocardial infarction.
    Clifford DM; Fisher SA; Brunskill SJ; Doree C; Mathur A; Watt S; Martin-Rendon E
    Cochrane Database Syst Rev; 2012 Feb; (2):CD006536. PubMed ID: 22336818
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Direct autologous bone marrow-derived stem cell transplantation for ischemic heart disease: a meta-analysis.
    Wen Y; Meng L; Xie J; Ouyang J
    Expert Opin Biol Ther; 2011 May; 11(5):559-67. PubMed ID: 21388335
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Stem cells after myocardial infarction].
    Schächinger V; Dimmeler S; Zeiher AM
    Herz; 2006 Apr; 31(2):127-36; quiz 142-3. PubMed ID: 16738836
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intracoronary infusion of bone marrow-derived selected CD34+CXCR4+ cells and non-selected mononuclear cells in patients with acute STEMI and reduced left ventricular ejection fraction: results of randomized, multicentre Myocardial Regeneration by Intracoronary Infusion of Selected Population of Stem Cells in Acute Myocardial Infarction (REGENT) Trial.
    Tendera M; Wojakowski W; Ruzyłło W; Chojnowska L; Kepka C; Tracz W; Musiałek P; Piwowarska W; Nessler J; Buszman P; Grajek S; Breborowicz P; Majka M; Ratajczak MZ;
    Eur Heart J; 2009 Jun; 30(11):1313-21. PubMed ID: 19208649
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical trials using autologous bone marrow and peripheral blood-derived progenitor cells in patients with acute myocardial infarction.
    Tendera M; Wojakowski W
    Folia Histochem Cytobiol; 2005; 43(4):233-5. PubMed ID: 16382891
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is the measurement of left ventricular ejection fraction the proper end point for cell therapy trials? An analysis of the effect of bone marrow mononuclear stem cell administration on left ventricular ejection fraction after ST-segment elevation myocardial infarction when evaluated by cardiac magnetic resonance imaging.
    Traverse JH; Henry TD; Moye' LA
    Am Heart J; 2011 Oct; 162(4):671-7. PubMed ID: 21982659
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.